Ann Rich

707 total citations
18 papers, 524 citations indexed

About

Ann Rich is a scholar working on Experimental and Cognitive Psychology, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Ann Rich has authored 18 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Experimental and Cognitive Psychology, 5 papers in Cognitive Neuroscience and 3 papers in Pharmacology. Recurrent topics in Ann Rich's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Mental Health Research Topics (4 papers) and Sleep and related disorders (3 papers). Ann Rich is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (10 papers), Mental Health Research Topics (4 papers) and Sleep and related disorders (3 papers). Ann Rich collaborates with scholars based in United Kingdom, Australia and New Zealand. Ann Rich's co-authors include David Nutt, Jon Nash, Caroline Bell, Spilios V. Argyropoulos, David H. Wegman, Jane Hicks, Susan J. Wilson, Sean Hood, Jayne Bailey and Sue Wilson and has published in prestigious journals such as Biological Psychiatry, The British Journal of Psychiatry and Psychopharmacology.

In The Last Decade

Ann Rich

18 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Rich United Kingdom 11 279 165 113 81 70 18 524
K. J. Brower United States 5 209 0.7× 201 1.2× 86 0.8× 60 0.7× 25 0.4× 10 432
Miquel Sánchez‐Turet Spain 15 227 0.8× 216 1.3× 232 2.1× 48 0.6× 64 0.9× 21 652
Thorsten Mikoteit Switzerland 15 388 1.4× 223 1.4× 158 1.4× 34 0.4× 55 0.8× 70 785
Christine Cherry United States 14 400 1.4× 293 1.8× 137 1.2× 41 0.5× 102 1.5× 17 747
Tam T. Nguyen‐Louie United States 12 131 0.5× 198 1.2× 97 0.9× 120 1.5× 118 1.7× 23 608
Norka E. Rabinovich United States 14 224 0.8× 126 0.8× 123 1.1× 101 1.2× 33 0.5× 27 758
Rebecca A. Chandler United States 9 377 1.4× 233 1.4× 178 1.6× 27 0.3× 56 0.8× 11 684
David P. Soskin United States 7 325 1.2× 102 0.6× 295 2.6× 44 0.5× 128 1.8× 11 681
Gosia Lipinska South Africa 13 328 1.2× 269 1.6× 128 1.1× 20 0.2× 26 0.4× 32 546
Roberto A. Dominguez United States 10 199 0.7× 171 1.0× 167 1.5× 60 0.7× 61 0.9× 20 480

Countries citing papers authored by Ann Rich

Since Specialization
Citations

This map shows the geographic impact of Ann Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Rich more than expected).

Fields of papers citing papers by Ann Rich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Rich. The network helps show where Ann Rich may publish in the future.

Co-authorship network of co-authors of Ann Rich

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Rich. A scholar is included among the top collaborators of Ann Rich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Rich. Ann Rich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Christmas, David M., Alison Diaper, Sue Wilson, et al.. (2014). A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers. Human Psychopharmacology Clinical and Experimental. 29(2). 163–171. 3 indexed citations
2.
Diaper, Alison, Ann Rich, Sue Wilson, et al.. (2013). Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double‐blind, placebo‐controlled study of orthostatic challenge, blood pressure and heart rate. Human Psychopharmacology Clinical and Experimental. 28(6). 562–575. 13 indexed citations
3.
Diaper, Alison, Ann Rich, G. R. Dawson, et al.. (2012). The effect of a clinically effective and non‐effective dose of lorazepam on 7.5% CO2‐induced anxiety. Human Psychopharmacology Clinical and Experimental. 27(6). 540–548. 7 indexed citations
4.
Diaper, Alison, Ann Rich, Kevin J. Craig, et al.. (2012). Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic. Journal of Psychopharmacology. 27(2). 135–145. 9 indexed citations
5.
Morris, Kelly, Jayne Bailey, John Potokar, et al.. (2010). Effects of 7.5% CO2 challenge in generalized anxiety disorder. Journal of Psychopharmacology. 25(1). 43–51. 27 indexed citations
6.
Carhart‐Harris, Robin, Tom A. Williams, Ben Sessa, et al.. (2010). The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. Journal of Psychopharmacology. 25(11). 1562–1567. 35 indexed citations
7.
Bell, Caroline, Sean Hood, John Potokar, et al.. (2009). Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder. Psychopharmacology. 213(2-3). 593–602. 7 indexed citations
8.
Nash, Jon, et al.. (2008). Assessment of GABAABenzodiazepine Receptor (GBzR) Sensitivity in Patients with Alcohol Dependence. Alcohol and Alcoholism. 43(6). 614–618. 4 indexed citations
9.
Hood, Sean, et al.. (2008). Irritable Bowel Syndrome Patients Exhibit Depressive and Anxiety Scores in the Subsyndromal Range. ResearchOnline@ND (The University of Notre Dame). 2(1). 12–22. 3 indexed citations
10.
Wilson, Sue, Jayne Bailey, Ann Rich, et al.. (2005). The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. Journal of Psychopharmacology. 19(6). 609–613. 25 indexed citations
11.
Cleaver, Karen & Ann Rich. (2005). Sexual health promotion: the barriers school nurses face.. PubMed. 78(12). 429–32. 11 indexed citations
12.
Argyropoulos, Spilios V., Sean Hood, Caroline Bell, et al.. (2004). Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biological Psychiatry. 56(7). 503–509. 69 indexed citations
13.
Argyropoulos, Spilios V., Jane Hicks, Jon Nash, et al.. (2003). Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Research. 120(2). 179–190. 97 indexed citations
14.
Bell, Caroline, Sue Wilson, Ann Rich, Jayne Bailey, & David Nutt. (2003). Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Psychopharmacology. 166(2). 102–110. 11 indexed citations
15.
Hicks, Jane, Spilios V. Argyropoulos, Ann Rich, et al.. (2002). Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. The British Journal of Psychiatry. 180(6). 528–535. 62 indexed citations
16.
Bell, Caroline, Jon Nash, Sean Hood, et al.. (2002). Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. Journal of Psychopharmacology. 16(1). 5–14. 67 indexed citations
17.
Potokar, John, et al.. (2000). GABAAbenzodiazepine receptor (GBzR) sensitivity: test-retest reliability in normal volunteers. Human Psychopharmacology Clinical and Experimental. 15(4). 281–286. 1 indexed citations
18.
Rich, Ann & David H. Wegman. (1995). Reflection and critical incident analysis: ethical and moral implications of their use within nursing and midwifery education. Journal of Advanced Nursing. 22(6). 1050–1057. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. J. Brower Breakdown of academic impact, for papers by Miquel Sánchez‐Turet Breakdown of academic impact, for papers by Thorsten Mikoteit Breakdown of academic impact, for papers by Christine Cherry Breakdown of academic impact, for papers by Tam T. Nguyen‐Louie Breakdown of academic impact, for papers by Norka E. Rabinovich Breakdown of academic impact, for papers by Rebecca A. Chandler Breakdown of academic impact, for papers by David P. Soskin Breakdown of academic impact, for papers by Gosia Lipinska Breakdown of academic impact, for papers by Roberto A. Dominguez
Rankless by CCL
2026